Evidence map›Paper›PMID 32655522›Full record

ArticleFrontiers in microbiology2020

Molecular Characterization and Antibiotic Resistant Profiles of

Leyi Zhang, Yi Li, Yongqiang Shao, Yuqin Hu, Huihuang Lou, Xiaonan Chen, Yuejin Wu, Lingling Mei, Biao Zhou, Xibin Zhang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Characterization and application of a novelCurrent research in food science · 2025
    Article
  4. Article
  5. Article
  6. Frontiers in veterinary science · 2024
    Article
  7. Article
  8. Food science & nutrition · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Antibiotic Resistance in Bacteria-A Review.Antibiotics (Basel, Switzerland) · 2022
    Review
  13. Article
  14. Article
  15. Global epidemiology of campylobacteriosis and the impact of COVID-19.Frontiers in cellular and infection microbiology · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Prevalence and Antimicrobial Resistance ofBioMed research international · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Leyi ZhangWenzhou Center for Disease Control and Prevention, Wenzhou, China.
Yi LiWenzhou Center for Disease Control and Prevention, Wenzhou, China.
Yongqiang ShaoWenzhou Center for Disease Control and Prevention, Wenzhou, China.
Yuqin HuWenzhou Center for Disease Control and Prevention, Wenzhou, China.
Huihuang LouWenzhou Center for Disease Control and Prevention, Wenzhou, China.
Xiaonan ChenOuhai Center for Disease Control and Prevention, Ouhai, China.
Yuejin WuWenzhou Center for Disease Control and Prevention, Wenzhou, China.
Lingling MeiZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Biao ZhouZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Xibin ZhangNew Hope Liuhe Co., Ltd., Beijing, China.
Wenwu YaoZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Lei FangZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Yanjun ZhangZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Zhejiang Center for Disease Control and Prevention · CNNew Hope Liuhe (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Campylobacterhuman fecesMLSTmultidrug resistancePFGEpoultry

Identifiers

PMID32655522
PMCPMC7324532
OpenAlexW3036094384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.